Table 1.
Clinical presentation of patients enrolled, including all patients and patients positive for Helicobacter by polymerase chain reaction technique
| Overall group | Helicobacter spp.+ | ||
|---|---|---|---|
| n = 36 | n = 12 | ||
| Bile + | 5 | ||
| Tissue + | 4 | ||
| Bile and tissue + | 3 | ||
| Median age, years | 48.5 | 52.0 | |
| % female (median age) | 52.8 (48.0) | 50 (54.0) | |
| % male (median age) | 48.2 (50.5) | 50 (50.5) | |
| Took antibiotics within 1 year, n (%) | 23 (63.9) | 7 (58.3) | |
| Unknown antibiotic use, n (%) | 5 (13.9) | 2 (16.7) | |
| Pathology results | |||
| Chronic cholecystitis, n (%) | 34 (94.4) | 11 (91.7) | |
| Cholesterolosis, n (%) | 10 (27.7) | 4 (33.3) | |
| Clinical history, prior diagnoses | |||
| GORD, n (%) | 16 (44.4) | 5 (41.7) | |
| Gastritis, n (%) | 4 (11.1) | 1 (8.3) | |
| Unknown, n (%) | 3 (8.3) | 1 (8.3) | |
| Helicobacter pylori serology | |||
| Anti-H. pylori, n (%) | 10 (27.8) | 6 (50) | |
| Anti-CagA, n (%) | 5 (13.9) | 2 (16.7) | |
GORD, gastro-oesophageal reflux disease